Aim: Assessment of the prevalence and prognostic value of gastroenterological manifestations in patients with COVID-19.
Materials And Methods: A single-center retrospective cohort study was carried out. Only cases with laboratory confirmed detection of SARS-CoV-2 virus RNA using polymerase chain reaction in oro-/nasopharyngeal smear samples were subject to analysis.